CIK: 0001039067 · Show all filings
Period: Q3 2022 (← Previous) (Next →)
Filing Date: Nov 10, 2022
Total Value ($000): $179,487 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IEMG | ISHARES CORE MSCI EMERGING MARKETS ETF | 2,953,000 | $126,920 | 70.7% | $59.20 | — | CORE MSCI EMKT | 46434G103 |
| DUOL | DUOLINGO INC | 543,523 | $51,760 | 28.8% | $137.73 | -29.3% | CL A COM | 26603R106 |
| — | NEUBASE THERAPEUTICS INC | 939,412 | $371 | 0.2% | $2.81 | — | COM | 64132K102 |
| VERA | VERA THERAPEUTICS INC | 16,060 | $342 | 0.2% | $22.12 | -15.4% | CL A | 92337R101 |
| — | PREDICTIVE ONCOLOGY INC | 207,144 | $75 | 0.0% | $0.95 | — | COM NEW | 74039M200 |
| IHT | INNSUITES HOSPITALITY TR | 10,000 | $19 | 0.0% | $3.13 | -20.2% | SH BEN INT | 457919108 |